http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100981995-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2008-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100981995-B1 |
| titleOfInvention | Polynucleotide encoding F-M fusion protein and composition for promoting wound healing comprising the same |
| abstract | The present invention relates to a polynucleotide encoding a FRM-EGF fusion protein and a composition for promoting wound healing comprising the same, more specifically, a polynucleotide encoding a FRM-EGF fusion protein, a vector comprising the polynucleotide, and the Provided are a wound healing promoting composition comprising the vector as an active ingredient. The fusion protein of the present invention is suitable for gene therapy because it has high protein expression efficiency and extracellular excretion effect, and has a remarkable effect on wound healing effect, neovascularization and dermatitis relief.n n n n FRM, EGF, FRM-EGF fusion protein, wound healing, neovascularization, dermatitis |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200098459-A |
| priorityDate | 2008-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 739.